Biotech 2001 to Offer Credit for Pennsylvania Licensed Attorneys

Apr 18, 2001, 01:00 ET from Biotechnology Council of New Jersey, Inc. from ,Pennsylvania Biotechnology

    TRENTON, N.J., April 18 /PRNewswire/ -- Pennsylvania licensed attorneys
 will receive CLE credit for attending Biotech 2001: Opportunities in the
 Nation's Pharmaceutical Center, which will take place on April 23-24, 2001 at
 the Atlantic City Convention Center and the Atlantic City Sheraton.  The
 Pennsylvania Continuing Legal Education Board has approved Symposium attendees
 to receive up to 11 CLE credits.  The Symposium is co-sponsored by the
 Biotechnology Council of New Jersey (BCNJ) and the Pennsylvania Biotechnology
 Association (PABIOTECH).
     This year's Symposium features a workshop, entitled Law and Biotechnology,
 which will examine issues in the law that executives and attorneys need to
 understand to successfully manage transactions in the biotechnology arena.
 The workshop features prominent speakers Michael J. Malinowski, Professor of
 Law, Widener University Law School and Author of Biotechnology: Law, Business,
 and Regulation; and Manya Deehr, Partner, Morgan, Lewis & Bockius LLP.  The
 speakers will discuss recent deals and current legal issues facing the
 biotechnology industry.
     This year's Symposium also includes focus panels such as Finding an
 International Pharmaceutical Partner; Gene Therapy and the Future of Medicine;
 and Overview of the Industry.  Other topics include innovation in clinical
 trials; financial disclosure; hiring and retaining critical scientists and
 executives; women's health; drug pricing issues; biopartnering; and a round-up
 of what's in the pipeline in research institutions in our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Celgene
 Corporation, Centocor, Inc., Cephalon, Inc., Cytogen Corporation, Dechert,
 Delsys Pharmaceutical Corporation, Ernst & Young, GlaxoSmithKline, Greater
 Philadelphia First, Government of Canada, Harkins Cunningham, Imperial Bank,
 Kirkpatrick & Lockhart LLP, Medarex, Inc., Merck & Company, Morgan, Lewis &
 Bockius LLP, NEOSE Technologies, Inc., New Jersey Economic Development
 Authority, Ortho Biotech, Inc., PECO Energy Company, Pennsylvania Department
 of Community and Economic Development, Pharmacia, Inc, Pittsburgh Technology
 Council, Pittsburgh Regional Alliance, Port of Technology - A Science Center
 Company, PSE&G, QED Technologies, Inc., S.R. One, Limited, University of
 Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 

SOURCE Biotechnology Council of New Jersey, Inc.; Pennsylvania Biotechnology
    TRENTON, N.J., April 18 /PRNewswire/ -- Pennsylvania licensed attorneys
 will receive CLE credit for attending Biotech 2001: Opportunities in the
 Nation's Pharmaceutical Center, which will take place on April 23-24, 2001 at
 the Atlantic City Convention Center and the Atlantic City Sheraton.  The
 Pennsylvania Continuing Legal Education Board has approved Symposium attendees
 to receive up to 11 CLE credits.  The Symposium is co-sponsored by the
 Biotechnology Council of New Jersey (BCNJ) and the Pennsylvania Biotechnology
 Association (PABIOTECH).
     This year's Symposium features a workshop, entitled Law and Biotechnology,
 which will examine issues in the law that executives and attorneys need to
 understand to successfully manage transactions in the biotechnology arena.
 The workshop features prominent speakers Michael J. Malinowski, Professor of
 Law, Widener University Law School and Author of Biotechnology: Law, Business,
 and Regulation; and Manya Deehr, Partner, Morgan, Lewis & Bockius LLP.  The
 speakers will discuss recent deals and current legal issues facing the
 biotechnology industry.
     This year's Symposium also includes focus panels such as Finding an
 International Pharmaceutical Partner; Gene Therapy and the Future of Medicine;
 and Overview of the Industry.  Other topics include innovation in clinical
 trials; financial disclosure; hiring and retaining critical scientists and
 executives; women's health; drug pricing issues; biopartnering; and a round-up
 of what's in the pipeline in research institutions in our respective states.
     Sponsors to date include Aventis Pharmaceuticals, Ballard Spahr Andrews &
 Ingersoll, Ben Franklin Technology Partners, Biotechnology Industry
 Organization, Brettler Financial Group, BTG International, Inc., Celgene
 Corporation, Centocor, Inc., Cephalon, Inc., Cytogen Corporation, Dechert,
 Delsys Pharmaceutical Corporation, Ernst & Young, GlaxoSmithKline, Greater
 Philadelphia First, Government of Canada, Harkins Cunningham, Imperial Bank,
 Kirkpatrick & Lockhart LLP, Medarex, Inc., Merck & Company, Morgan, Lewis &
 Bockius LLP, NEOSE Technologies, Inc., New Jersey Economic Development
 Authority, Ortho Biotech, Inc., PECO Energy Company, Pennsylvania Department
 of Community and Economic Development, Pharmacia, Inc, Pittsburgh Technology
 Council, Pittsburgh Regional Alliance, Port of Technology - A Science Center
 Company, PSE&G, QED Technologies, Inc., S.R. One, Limited, University of
 Pittsburgh, and Wyeth Ayerst Laboratories.
     For more information about the program or to register, contact Symposium
 Headquarters at 800-231-0022.  Program details can also be found at
 www.newjerseybiotech.org and www.pabiotech.org.
     The Biotechnology Council of New Jersey and the Pennsylvania Biotechnology
 Association represent the biotechnology communities in their respective
 states.  Through their education and advocacy efforts, both associations work
 to advance biotechnology in the region.
 
 SOURCE  Biotechnology Council of New Jersey, Inc.; Pennsylvania Biotechnology